Download Full Text (4.6 MB)


  • Multidisciplinary Globe-Sparing Treatment for Lacrimal Gland Carcinoma Preserves Vision and Minimizes Morbidity: Until recently, the treatment of lacrimal gland carcinoma almost always required removal of the eye. But for some patients with these tumors, globe-sparing surgery followed by radiation therapy can preserve vision and decrease ocular morbidity and facial disfigurement.
  • Novel Trial Design Streamlines Development of Breast Cancer Therapies: Developing a cancer-fighting drug can take around a billion dollars and a dozen or more years. Even then, fail in clinical trials. To identify effective cancer therapies more quickly and efficiently, researchers have tuned to an innovative clinical model in which multiple treatments are investigated simultaneously and the study design is adapted as patient data accrue.
  • Targeted Therapy for High-Risk Melanoma May Forestall Recurrence: Although targeted agents have been approved for the treatment of metastatic melanoma, such agents typically are not used in patients with earlier-stage, respectable disease who have a high risk for recurrence. But a clinical trial of targeted therapy before and after surgery aims to prolong recurrence-free survival for patients with respectable high-risk melanoma.
  • HOUSE CALL: Interpreting Health News-Common mistakes in medical reporting

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Esmaeli, Bita; Frank, Steven; Moulder, Stacy; Berry, Donald A.; Esserman, Laura J.; Amaria, Rodabe; Wargo, Jennifer; Lacrimal Apparatus Diseases; Chemotherapy, Adjuvant; Eye Neoplasms; Orbital Neoplasms; Radiotherapy; Neoadjuvant Therapy; Breast Neoplasms; Melanoma; Molecular Targeted Therapy; Clinical Trials as Topic; Mitogen-Activated Protein Kinase Kinases; Health Education.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 60, Number 04, April 2015